Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,718,571
-
Share change
-
-1,881,090
-
Total reported value
-
$659,965,411
-
Put/Call ratio
-
138%
-
Price per share
-
$24.70
-
Number of holders
-
166
-
Value change
-
-$90,243,187
-
Number of buys
-
82
-
Number of sells
-
81
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q4 2020
As of 31 Dec 2020,
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,718,571 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., FIRST TRUST ADVISORS LP, JPMORGAN CHASE & CO, AMERIPRISE FINANCIAL INC, GOLDMAN SACHS GROUP INC, MACQUARIE GROUP LTD, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
166
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.